News - Page 195 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyched Wellness Submits a Provisional Patent Application For AME-1

Psyched Wellness Submits a Provisional Patent Application For AME-1

Post published:March 17, 2021
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug DMT Clinical Research Program for Stroke

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug DMT Clinical Research Program for Stroke

Post published:March 17, 2021
Post category:Press Release

Read more about the article Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch

Post published:March 16, 2021
Post category:Press Release

Read more about the article World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific and Clinical Advisor

World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific and Clinical Advisor

Post published:March 16, 2021
Post category:Press Release

Read more about the article Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders

Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders

Post published:March 16, 2021
Post category:Press Release

Read more about the article Red Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit

Red Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit

Post published:March 16, 2021
Post category:Press Release

Read more about the article Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study

Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study

Post published:March 16, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Provides Update on European Operations

Mydecine Innovations Group Provides Update on European Operations

Post published:March 16, 2021
Post category:Press Release

Read more about the article DC’s Initiative 81 Becomes Law: Effectively Decriminalizes Entheogenic Plants and Fungi

DC’s Initiative 81 Becomes Law: Effectively Decriminalizes Entheogenic Plants and Fungi

Post published:March 15, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50% Decrease in Opioid Self-Administration in a Predictive Rodent Model

Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50% Decrease in Opioid Self-Administration in a Predictive Rodent Model

Post published:March 15, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.